The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- PMID: 18950759
- DOI: 10.1016/j.fertnstert.2008.06.035
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Abstract
Objective: To review all available data and recommend a definition for polycystic ovary syndrome (PCOS) based on published peer-reviewed data, whether already in use or not, to guide clinical diagnosis and future research.
Design: Literature review and expert consensus.
Setting: Professional society.
Patients: None.
Intervention(s): None.
Main outcome measure(s): A systematic review of the published peer-reviewed medical literature, by querying MEDLINE databases, to identify studies evaluating the epidemiology or phenotypic aspects of PCOS.
Result(s): The Task Force drafted the initial report, following a consensus process via electronic communication, which was then reviewed and critiqued by the Androgen Excess and PCOS (AE-PCOS) Society AE-PCOS Board of Directors. No section was finalized until all members were satisfied with the contents, and minority opinions noted. Statements were not included that were not supported by peer-reviewed evidence.
Conclusion(s): Based on the available data, it is the view of the AE-PCOS Society Task Force that PCOS should be defined by the presence of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction (oligo-anovulation and/or polycystic ovaries), and the exclusion of related disorders. However, a minority considered the possibility that there may be forms of PCOS without overt evidence of hyperandrogenism, but recognized that more data are required before validating this supposition. Finally, the Task Force recognized and fully expects that the definition of this syndrome will evolve over time to incorporate new research findings.
Comment in
-
Criteria for the polycystic ovary syndrome.Fertil Steril. 2009 Jul;92(1):e14; author reply e15. doi: 10.1016/j.fertnstert.2009.03.110. Epub 2009 May 29. Fertil Steril. 2009. PMID: 19481742 No abstract available.
Similar articles
-
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.J Clin Endocrinol Metab. 2006 Nov;91(11):4237-45. doi: 10.1210/jc.2006-0178. Epub 2006 Aug 29. J Clin Endocrinol Metab. 2006. PMID: 16940456
-
Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.Hum Reprod. 2019 Nov 1;34(11):2254-2265. doi: 10.1093/humrep/dez185. Hum Reprod. 2019. PMID: 31751476
-
Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.Fertil Steril. 2021 Jun;115(6):1557-1568. doi: 10.1016/j.fertnstert.2020.12.015. Epub 2021 Feb 15. Fertil Steril. 2021. PMID: 33602559 Free PMC article.
-
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22. Hum Reprod. 2016. PMID: 27664216 Review.
-
Polycystic ovary syndrome in adolescent girls.Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):56-66. doi: 10.1097/MED.0000000000000309. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 27906711 Review.
Cited by
-
Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.J Clin Endocrinol Metab. 2012 Dec;97(12):4650-5. doi: 10.1210/jc.2012-1440. Epub 2012 Sep 19. J Clin Endocrinol Metab. 2012. PMID: 22993032 Free PMC article.
-
CISD2 regulates oxidative stress and mitophagy to maintain the balance of the follicular microenvironment in PCOS.Redox Rep. 2024 Dec;29(1):2377870. doi: 10.1080/13510002.2024.2377870. Epub 2024 Jul 15. Redox Rep. 2024. PMID: 39010730 Free PMC article.
-
Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women.PLoS One. 2015 Apr 15;10(4):e0123608. doi: 10.1371/journal.pone.0123608. eCollection 2015. PLoS One. 2015. PMID: 25874409 Free PMC article.
-
Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.Endocrine. 2016 Dec;54(3):798-807. doi: 10.1007/s12020-016-1062-y. Epub 2016 Aug 3. Endocrine. 2016. PMID: 27484772
-
Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols.Int J Endocrinol. 2016;2016:6306410. doi: 10.1155/2016/6306410. Epub 2016 Aug 4. Int J Endocrinol. 2016. PMID: 27579037 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical